{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:26:31Z","timestamp":1784366791112,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.transci.2025.104186","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:33:04Z","timestamp":1750447984000},"page":"104186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes"],"prefix":"10.1016","volume":"64","author":[{"given":"Burcu","family":"Aslan Candir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazik","family":"Okumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek Yonal","family":"Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem","family":"Namdaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Merter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Koroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba","family":"Zorlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik Onur","family":"Tiryaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Katircilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant","family":"Uzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Seyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Murat","family":"Ozbalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Sinan","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgay","family":"Ula\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdal","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fevzi","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transci.2025.104186_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/14740330902918273","article-title":"Safety of conditioning agents for allogeneic haematopoietic transplantation","volume":"8","author":"Bacher","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"10.1016\/j.transci.2025.104186_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40262-018-0647-4","article-title":"Treosulfan pharmacokinetics and its variability in pediatric and adult patients undergoing conditioning prior to hematopoietic stem cell transplantation: current state of the art, in-depth analysis, and perspectives","volume":"57","author":"Roma\u0144ski","year":"2018","journal-title":"Clin Pharm"},{"issue":"2","key":"10.1016\/j.transci.2025.104186_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","article-title":"Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Casper","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2025.104186_bib4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbmt.2014.08.020","article-title":"Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial","volume":"20","author":"Burroughs","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2025.104186_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1705259","article-title":"Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)","volume":"37","author":"Kr\u00f6ger","year":"2006","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2025.104186_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41409-024-02241-2","article-title":"Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients- a clinical trial to registry data comparison","volume":"59","author":"Beelen","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2025.104186_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/bloodadvances.2024014548","article-title":"Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM","volume":"9","author":"Kalwak","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.transci.2025.104186_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major","volume":"143","author":"Bernardo","year":"2008","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.transci.2025.104186_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPH.0000000000002735","article-title":"Treosulfan versus busulfan-based conditioning in pediatric patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"45","author":"Wu","year":"2023","journal-title":"J Pedia Hematol Oncol"},{"issue":"2","key":"10.1016\/j.transci.2025.104186_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbmt.2019.09.032","article-title":"Clofarabine and treosulfan as conditioning for matched related and unrelated hematopoietic stem cell transplantation: results from the Clo3o Phase II Trial","volume":"26","author":"Peccatori","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2025.104186_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.591363","article-title":"Long-term outcomes of treosulfan- vs. busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myeloid leukemia before hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.transci.2025.104186_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbmt.2017.12.776","article-title":"Intravenous busulfan compared with treosulfan-based conditioning for allogeneic stem cell transplantation in acute myeloid leukemia: a study on behalf of the acute leukemia working party of european society for blood and marrow transplantation","volume":"24","author":"Shimoni","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"10.1016\/j.transci.2025.104186_bib13","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.transci.2025.104186_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.hemonc.2019.09.002","article-title":"Comparative effectiveness of busulfan\/cyclophosphamide versus busulfan\/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome","volume":"13","author":"Patel","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10.1016\/j.transci.2025.104186_bib15","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.jtct.2023.11.018","article-title":"Peripheral blood haploidentical allogeneic stem cell transplantation in older adults with acute myeloid leukemia and myelodysplastic syndromes demonstrates long term survival, results from australia and new zealand transplant and cellular therapies","volume":"30","author":"Abadir","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"10","key":"10.1016\/j.transci.2025.104186_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000952","article-title":"Thiotepa-busulfan-fludarabine compared to treosulfan-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with acute myeloid leukemia in remission: a study from the acute leukemia working party of the EBMT","volume":"7","author":"Saraceni","year":"2023","journal-title":"Hemasphere"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:17:52Z","timestamp":1753352272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050225001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1473050225001235"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2025.104186","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2025.104186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104186"}}